Impact of FDA recommendations on patient-reported outcome inclusion in ovarian cancer clinical trials

被引：0
|
作者：
Aviki, E. M. [1 ]
Armbruster, S. [2 ]
Green, A. K. [1 ]
Blinder, V. S. [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
GYNECOLOGIC ONCOLOGY | 2018年 / 149卷
关键词：
D O I：
10.1016/j.ygyno.2018.04.295
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
285
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [1] Patient-Reported Outcomes Clinical Trials in Ovarian Cancer
    Carey, Mark S.
    Gotay, Carolyn
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (04) : 782 - 787
  • [2] Patient-reported outcomes in ovarian cancer clinical trials
    Friedlander, M. L.
    King, M. T.
    ANNALS OF ONCOLOGY, 2013, 24 : 64 - 68
  • [3] PATIENT-REPORTED OUTCOMES (PROS) IN OVARIAN CANCER CLINICAL TRIALS
    Pease, S.
    Barsdorf, A., I
    VALUE IN HEALTH, 2015, 18 (03) : A210 - A210
  • [4] Developing patient-reported outcome measures for pain clinical trials: IMMPACT recommendations
    Turk, Dennis C.
    Dworkin, Robert H.
    Burke, Laurie B.
    Gershon, Richard
    Rothman, Margaret
    Scott, Jane
    Allen, Robert R.
    Atkinson, J. Hampton
    Chandler, Julie
    Cleeland, Charles
    Cowan, Penny
    Dimitrova, Rozalina
    Dionne, Raymond
    Farrar, John T.
    Haythornthwaite, Jennifer A.
    Hertz, Sharon
    Jadad, Alejandro R.
    Jensen, Mark P.
    Kellstein, David
    Kerns, Robert D.
    Manning, Donald C.
    Martin, Susan
    Max, Mitchell B.
    McDermott, Michael P.
    McGrath, Patrick
    Moulin, Dwight E.
    Nurmikko, Turo
    Quessy, Steve
    Raja, Srinivasa
    Rappaport, Bob A.
    Rauschkolb, Christine
    Robinson, James P.
    Royal, Mike A.
    Simon, Lee
    Stauffer, Joseph W.
    Stucki, Gerold
    Tollett, Jane
    von Stein, Thorsten
    Wallace, Mark S.
    Wernicke, Joachim
    White, Richard E.
    Williams, Amanda C.
    Witter, James
    Wyrwich, Kathleen W.
    PAIN, 2006, 125 (03) : 208 - 215
  • [5] Preliminary development of recommendations for the inclusion of patient-reported outcome measures in clinical quality registries
    Rasa Ruseckaite
    Ashika D. Maharaj
    Joanne Dean
    Karolina Krysinska
    Ilana N. Ackerman
    Angela L. Brennan
    Ljoudmila Busija
    Helen Carter
    Arul Earnest
    Christopher B. Forrest
    Ian A. Harris
    Janet Sansoni
    Susannah Ahern
    BMC Health Services Research, 22
  • [6] Preliminary development of recommendations for the inclusion of patient-reported outcome measures in clinical quality registries
    Ruseckaite, Rasa
    Maharaj, Ashika D.
    Dean, Joanne
    Krysinska, Karolina
    Ackerman, Ilana N.
    Brennan, Angela L.
    Busija, Ljoudmila
    Carter, Helen
    Earnest, Arul
    Forrest, Christopher B.
    Harris, Ian A.
    Sansoni, Janet
    Ahern, Susannah
    BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [7] Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: Recommendations on incorporating patient-reported outcomes in clinical trials in epithelial ovarian cancer
    Joly, Florence
    Hilpert, Felix
    Okamoto, Aikou
    Stuart, Gavin
    Ochiai, Kasunori
    Friedlander, Michael
    EUROPEAN JOURNAL OF CANCER, 2017, 78 : 133 - 138
  • [8] An FDA example of patient-reported Physical Function (PF) analysis in cancer clinical trials
    Strazzeri, Marian
    Johnson, Laura Lee
    Sridhara, Rajeshwari
    Kluetz, Paul
    Komo, Scott
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 141 - 141
  • [9] Access to patient-reported outcome (PRO) instruments and their translations in the light of FDA recommendations
    Anfray, C.
    Emery, M. P.
    VALUE IN HEALTH, 2008, 11 (03) : A180 - A180
  • [10] A DATABASE REVIEW OF PATIENT-REPORTED OUTCOME STUDIES IN EORTC CANCER CLINICAL TRIALS
    Bottomley, A.
    Quinten, C.
    Mauer, M.
    Taphoorn, M.
    Flechtner, H. H.
    Koller, M.
    Ghislain, I
    Coens, C.
    VALUE IN HEALTH, 2010, 13 (07) : A276 - A276
12345